ALMAC CLINICAL TECHNOLOGIES LIMITED
ALMAC CLINICAL TECHNOLOGIES LIMITED is a Private limited company (Ltd.) registered in United Kingdom under NI061202, and its current status with Companies House is active. The company was incorporated on 10 October 2006 and lists its registered address as CRAIGAVON, United Kingdom. 1 shareholder is on record for ALMAC CLINICAL TECHNOLOGIES LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 23 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for ALMAC CLINICAL TECHNOLOGIES LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.
The largest of these is ALMAC GROUP (UK) LTD, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| ALMAC GROUP (UK) LTD | 100% | Companies House |
Officers
5
The Director of ALMAC CLINICAL TECHNOLOGIES LIMITED currently on record is Alan Armstrong; five officers are currently on record for ALMAC CLINICAL TECHNOLOGIES LIMITED, filed with Companies House.
The register reports 12 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at ALMAC CLINICAL TECHNOLOGIES LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
ALMAC CLINICAL TECHNOLOGIES LIMITED sits 3 levels below its ultimate parent, THE MCCLAY FOUNDATION, registered in United Kingdom. The full chain up to THE MCCLAY FOUNDATION is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by ALMAC CLINICAL TECHNOLOGIES LIMITED's own shareholder record.
THE MCCLAY FOUNDATION
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns ALMAC CLINICAL TECHNOLOGIES LIMITED?
One shareholder is currently on record for ALMAC CLINICAL TECHNOLOGIES LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is ALMAC GROUP (UK) LTD, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is ALMAC CLINICAL TECHNOLOGIES LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for ALMAC CLINICAL TECHNOLOGIES LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does ALMAC CLINICAL TECHNOLOGIES LIMITED have on record?
1 shareholder is shown on record for ALMAC CLINICAL TECHNOLOGIES LIMITED.
What is ALMAC CLINICAL TECHNOLOGIES LIMITED's company registration number?
ALMAC CLINICAL TECHNOLOGIES LIMITED's registration number is NI061202, filed with Companies House in United Kingdom. Its current status on the register is active.
Is ALMAC CLINICAL TECHNOLOGIES LIMITED still an active company?
ALMAC CLINICAL TECHNOLOGIES LIMITED's status on Companies House is listed as active.
When was ALMAC CLINICAL TECHNOLOGIES LIMITED incorporated?
ALMAC CLINICAL TECHNOLOGIES LIMITED was incorporated on 10 October 2006, according to Companies House.
What is ALMAC CLINICAL TECHNOLOGIES LIMITED's registered address?
The registered address on file for ALMAC CLINICAL TECHNOLOGIES LIMITED is CRAIGAVON, United Kingdom.
What legal structure is ALMAC CLINICAL TECHNOLOGIES LIMITED registered as?
ALMAC CLINICAL TECHNOLOGIES LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of ALMAC CLINICAL TECHNOLOGIES LIMITED?
The Director of ALMAC CLINICAL TECHNOLOGIES LIMITED currently on record is Alan Armstrong; five officers are currently on record for ALMAC CLINICAL TECHNOLOGIES LIMITED, filed with Companies House. Management authority at ALMAC CLINICAL TECHNOLOGIES LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does ALMAC CLINICAL TECHNOLOGIES LIMITED have a parent company or subsidiaries?
ALMAC CLINICAL TECHNOLOGIES LIMITED sits 3 levels below its ultimate parent, THE MCCLAY FOUNDATION, registered in United Kingdom.
Can Zavia monitor changes to ALMAC CLINICAL TECHNOLOGIES LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to ALMAC CLINICAL TECHNOLOGIES LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access ALMAC CLINICAL TECHNOLOGIES LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like ALMAC CLINICAL TECHNOLOGIES LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 23 October 2026.